Jatoi, A., Ou, F., Ahn, D. H., Zemla, T. J., Le-Rademacher, J. G., Boland, P., Ciombor, K. K., Jacobs, N. L., Pasche, B., Cleary, J. M., McCune, J. S., Pedersen, K. S., Barzi, A., Chiorean, E. G., Heying, E. N., Lenz, H., Sloan, J. A., Grothey, A., Lacouture, M. E., & Bekaii-Saab, T. (2021). preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial. Oncologist, 26, 610–618. http://access.bl.uk/ark:/81055/vdc_100151235874.0x000012